Multiple Sclerosis. Multiple sclerosis
Conditions
Interventions
Treatment - Drugs
Placebo
Sponsors
Vice Chancellor for research of Traditional Medicine Faculity of Tehran University of Medical Scienc
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Definite diagnosis of multiple sclerosis (MS)? No evidence or symptom of new attack of MS? Age between 18 to 50 years? One month after last attack, at least. Exclusion criteria: Severe depression? Pregnancy? History of skin allergy to Apiaceae family (carrot, anise…)? Taking drug for depression or fatigue such as amantadine, pemoline, modafinil, bupropion, fluoxetine… during or until 2 weeks from the entrance to the study. (Washout period = 2 weeks)? Starting the disease modifying drugs (such as interferon) within the recent 3 months? Using the energy drinks? Taking the anticoagulant drugs such as warfarin, heparin, low molecular heparins or aspirin? Diabetes mellitus.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue. Timepoint: at the begining of drug usage and after 4 weeks of the drug usage. Method of measurement: MFIS, FSS AND VAS QuestionareS.;Depression severity. Timepoint: at the begining of drug usage. Method of measurement: short form of Beck depression inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: after 4 weeks of drug usage. Method of measurement: questionare for side effects that developed by the researcher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Abbasi
Traditional Iranian medicine clinic of Tehran University of Medical Sciences
Outcome results
None listed